FDA Proposal Would Expand Sunscreen Ingredients Allowed in U.S.

On December 11–12, 2025, U.S. health regulators announced a proposal that could significantly expand the range of active ingredients permitted in over-the-counter sunscreens, bringing U.S. products more in line with formulations that have long been used in Europe, Asia, and other regions. The Food and Drug Administration (FDA) is moving to add new ingredients that are commonly found in sunscreens abroad to the list of approved substances for U.S. products. This move is aimed at providing manufacturers with greater flexibility in creating sunscreens that offer more effective protection against ultraviolet (UV) rays.

If the proposal is finalized after public comment and review, it could lead to a broader selection of sunscreen options available to consumers in the U.S. This would offer more choices for those looking to protect themselves from the harmful effects of sun exposure, especially in regions that experience high levels of UV radiation. The change could be particularly important in areas where dermatological health is at greater risk due to increased sun exposure, such as in places with hotter climates or where outdoor activities are more prevalent year-round.

For years, some ingredients widely used in sunscreens outside of the U.S. have not been approved by the FDA, limiting the types of products available domestically. The proposed rule changes could provide a more diverse set of sun protection products, potentially allowing for more advanced formulations that could offer improved or longer-lasting protection. This could also provide manufacturers with more options to cater to various consumer needs, such as sensitive skin formulations, water-resistant options, or sunscreens designed for specific age groups or skin tones.

The expansion of approved sunscreen ingredients could have significant implications for public health. Increased access to better sunscreen options may help address the growing concerns over skin cancer and other sun-related health issues, which are exacerbated by prolonged UV exposure. With skin cancer rates rising in many parts of the world, including the U.S., ensuring that consumers have access to high-quality sun protection is becoming more critical than ever.

However, the proposal is still in the review process, and public comment will be taken into account before any final decision is made. If the FDA moves forward with the changes, it could mark a significant shift in the way sunscreen products are developed and marketed in the United States, providing consumers with more choices to protect their skin and potentially reducing the risk of UV-related health problems.